Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Walmart
WMT
|
$1.12B |
| 2 |
Microsoft
MSFT
|
$700M |
| 3 |
Walt Disney
DIS
|
$589M |
| 4 |
Linde
LIN
|
$549M |
| 5 |
Apple
AAPL
|
$486M |
Top Sells
| 1 |
Yum China
YUMC
|
$518M |
| 2 |
Invesco S&P 500 Low Volatility ETF
SPLV
|
$480M |
| 3 |
Synopsys
SNPS
|
$424M |
| 4 |
Workday
WDAY
|
$406M |
| 5 |
Meta Platforms (Facebook)
META
|
$364M |
Sector Composition
| 1 | Technology | 23.57% |
| 2 | Financials | 12.22% |
| 3 | Industrials | 11.88% |
| 4 | Healthcare | 11.02% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3676
BioXcel Therapeutics
BTAI
$59M
| $53.1K | ﹤0.01% |
18,841
+4,690
| +33% | +$13.2K |
|
3677
AbCellera Biologics
ABCL
$1.25B
| $51.8K | ﹤0.01% |
+11,428
| New | +$51.8K |
|
3678
Cadiz
CDZI
$294M
| $51.7K | ﹤0.01% |
17,823
-62
| -0.3% | -$180 |
|
3679
Butterfly Network
BFLY
$405M
| $51.2K | ﹤0.01% |
47,407
-130,197
| -73% | -$141K |
|
3680
Citius Pharmaceuticals
CTXR
$22.6M
| $50.6K | ﹤0.01% |
56,355
-1,938
| -3% | -$1.74K |
|
3681
Redwire
RDW
$1.28B
| $49.8K | ﹤0.01% |
11,355
-28
| -0.2% | -$123 |
|
3682
Kaltura
KLTR
$246M
| $49.3K | ﹤0.01% |
36,520
-207
| -0.6% | -$279 |
|
3683
Seres Therapeutics
MCRB
$166M
| $48.7K | ﹤0.01% |
62,966
+5,966
| +10% | +$4.62K |
|
3684
Cambium Networks
CMBM
$21.5M
| $48.3K | ﹤0.01% |
+11,202
| New | +$48.3K |
|
3685
Akebia Therapeutics
AKBA
$833M
| $47.3K | ﹤0.01% |
25,835
-3,336
| -11% | -$6.11K |
|
|
OPTN
3686
DELISTED
OptiNose
OPTN
| $46.9K | ﹤0.01% |
32,097
-274
| -0.8% | -$400 |
|
|
MOND
3687
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $46.6K | ﹤0.01% |
20,173
-49
| -0.2% | -$113 |
|
|
EVA
3688
DELISTED
Enviva Inc.
EVA
| $46.1K | ﹤0.01% |
104,809
-43,715
| -29% | -$19.2K |
|
3689
ProKidney
PROK
$319M
| $46.1K | ﹤0.01% |
28,103
-833
| -3% | -$1.37K |
|
|
IVAC
3690
DELISTED
Intevac Inc
IVAC
| $45.2K | ﹤0.01% |
11,770
-442
| -4% | -$1.7K |
|
|
AMRN
3691
Amarin Corp
AMRN
$311M
| $44.5K | ﹤0.01% |
49,930
+2,564
| +5% | +$2.28K |
|
3692
Esperion Therapeutics
ESPR
$448M
| $43.8K | ﹤0.01% |
16,356
-6,820
| -29% | -$18.3K |
|
3693
Karyopharm Therapeutics
KPTI
$61.7M
| $42.2K | ﹤0.01% |
27,969
-502
| -2% | -$758 |
|
3694
Design Therapeutics
DSGN
$315M
| $42.2K | ﹤0.01% |
10,474
-463
| -4% | -$1.87K |
|
3695
Dakota Gold
DC
$468M
| $42K | ﹤0.01% |
17,732
-140
| -0.8% | -$332 |
|
3696
Vor Biopharma
VOR
$250M
| $41.2K | ﹤0.01% |
17,382
-656
| -4% | -$1.56K |
|
|
OMGA
3697
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $39.1K | ﹤0.01% |
10,708
-111
| -1% | -$405 |
|
3698
FiscalNote
NOTE
$73.2M
| $38.9K | ﹤0.01% |
29,277
-44
| -0.2% | -$59 |
|
|
ALLK
3699
DELISTED
Allakos
ALLK
| $38.5K | ﹤0.01% |
30,594
-1,139
| -4% | -$1.44K |
|
3700
Aclaris Therapeutics
ACRS
$209M
| $37.8K | ﹤0.01% |
30,498
-1,159
| -4% | -$1.44K |
|